Gavin Bennett

3.3k total citations · 1 hit paper
36 papers, 2.6k citations indexed

About

Gavin Bennett is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gavin Bennett has authored 36 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gavin Bennett's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Axon Guidance and Neuronal Signaling (9 papers) and Peptidase Inhibition and Analysis (8 papers). Gavin Bennett is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Axon Guidance and Neuronal Signaling (9 papers) and Peptidase Inhibition and Analysis (8 papers). Gavin Bennett collaborates with scholars based in United Kingdom, United States and Belgium. Gavin Bennett's co-authors include Elizabeth J. Bradbury, James W. Fawcett, Stephen B. McMahon, Lawrence Moon, Von R. King, Reena J. Popat, Susan D. Brain, Katerine Van Rietschoten, Liuhong Chen and Gemma Mudd and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Gavin Bennett

31 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chondroitinase ABC promotes functional recovery after spinal cord injury

2002 1.9k citations Elizabeth J. Bradbury, Lawrence Moon et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gavin Bennett United Kingdom	15	1.6k	888	706	658	543	36	2.6k
Yona Goldshmit Australia	28	997 0.6×	902 1.0×	390 0.6×	644 1.0×	337 0.6×	40	2.3k
Bernhard K. Mueller Germany	26	2.4k 1.5×	1.6k 1.8×	385 0.5×	1.1k 1.7×	745 1.4×	38	3.7k
Kevin K. Park United States	22	3.2k 2.1×	2.2k 2.4×	784 1.1×	1.9k 2.9×	364 0.7×	38	4.8k
Andrea Tedeschi United States	18	1.5k 1.0×	965 1.1×	630 0.9×	882 1.3×	254 0.5×	31	2.5k
Stefano Amadio Italy	25	716 0.5×	1.1k 1.2×	336 0.5×	828 1.3×	277 0.5×	46	3.0k
Carla Taveggia Italy	27	1.6k 1.0×	1.0k 1.2×	149 0.2×	900 1.4×	378 0.7×	44	2.7k
Alastair Wilkins United Kingdom	30	725 0.5×	979 1.1×	620 0.9×	744 1.1×	121 0.2×	71	2.8k
Jae K. Lee United States	28	2.0k 1.3×	1.2k 1.3×	1.3k 1.9×	1.2k 1.8×	174 0.3×	62	3.7k
Sjef Copray Netherlands	29	521 0.3×	1.3k 1.5×	347 0.5×	801 1.2×	242 0.4×	55	2.6k

Countries citing papers authored by Gavin Bennett

Since Specialization

Citations

This map shows the geographic impact of Gavin Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Bennett more than expected).

Fields of papers citing papers by Gavin Bennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Bennett. The network helps show where Gavin Bennett may publish in the future.

Co-authorship network of co-authors of Gavin Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Bennett. A scholar is included among the top collaborators of Gavin Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Bennett. Gavin Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McKean, Meredith, Leslie R. DeMars, Mengyao Li, et al.. (2024). Breaking from the paradigm of antibody-drug conjugates: Evaluation of clinical pharmacokinetics and safety of bicycle toxin conjugates (BTCs).. Journal of Clinical Oncology. 42(16_suppl). 3088–3088. 2 indexed citations

Walsh, Stephen J., Johanna Lahdenranta, Philip Huxley, et al.. (2024). Abstract 5807: Bicycle Toxin Conjugates®for the treatment of solid tumors. Cancer Research. 84(6_Supplement). 5807–5807.

Bashir, Babar, Judy S. Wang, Gerald S. Falchook, et al.. (2024). Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 42(29). 3443–3452. 8 indexed citations

Rigby, Michael, Gavin Bennett, Liuhong Chen, et al.. (2022). BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(12). 1747–1756. 41 indexed citations

Ngo, Kenneth, Elena V. Ivanova, Carly Campbell, et al.. (2022). Abstract 333: Activity of the erythropoietin-producing hepatocellular A2 receptor (EphA2) targeting Bicycle® Toxin Conjugate (BTC™) BCY6033 in EGFR inhibitor resistant non-small lung cancer (NSCLC) patient derived xenografts. Cancer Research. 82(12_Supplement). 333–333.

Berry, Philip, Julie Errington, Philip D. Jeffrey, et al.. (2021). Development of a Lc–Ms/Ms Method for the Quantification of Toxic Payload Dm1 Cleaved from Bt1718 in a Phase I Study. Bioanalysis. 13(2). 101–113. 26 indexed citations

Bennett, Gavin, Amy Brown, Gemma Mudd, et al.. (2020). MMAE Delivery Using the Bicycle Toxin Conjugate BT5528. Molecular Cancer Therapeutics. 19(7). 1385–1394. 77 indexed citations

Eder, Matthias, Silvia Pavan, Ulrike Bauder‐Wüst, et al.. (2019). Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors. Cancer Research. 79(4). 841–852. 49 indexed citations

Rigby, Mike, Paul Beswick, Gemma Mudd, et al.. (2019). Abstract 4479: BT8009: A bicyclic peptide toxin conjugate targeting Nectin-4 (PVRL4) displays efficacy in preclinical tumor models. Cancer Research. 79(13_Supplement). 4479–4479. 6 indexed citations

10.

Bennett, Gavin, Amy Brown, Gemma Mudd, Johanna Lahdenranta, & Nicholas Keen. (2019). Abstract 4481: BT5528, an EphA2-targeting Bicycle Toxin Conjugate (BTC): Profound efficacy without bleeding and coagulation abnormalities in animal models. Cancer Research. 79(13_Supplement). 4481–4481. 1 indexed citations

11.

Banerji, Udai, Natalie Cook, T.R. Jeffry Evans, et al.. (2018). A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours.. Journal of Clinical Oncology. 36(15_suppl). TPS2610–TPS2610. 10 indexed citations

12.

Bennett, Gavin, Philip Huxley, Amy Brown, et al.. (2018). Abstract 5855: Bicycle Drug Conjugates targeting EphA2 for the treatment of solid tumors: Discovery and selection of BT5528. Cancer Research. 78(13_Supplement). 5855–5855. 2 indexed citations

13.

Teufel, Daniel P., Gavin Bennett, Katerine Van Rietschoten, et al.. (2018). Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. Journal of Medicinal Chemistry. 61(7). 2823–2836. 30 indexed citations

14.

Perry, Benjamin, Gavin Bennett, George M. Buckley, et al.. (2008). Optimization of a series of multi-isoform PI3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5299–5302. 9 indexed citations

15.

Bradbury, Elizabeth J., Lawrence Moon, Reena J. Popat, et al.. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416(6881). 636–640. 1866 indexed citations breakdown →

16.

Robertson, Alan, Mark J. Banfield, Shelley Allen, et al.. (2001). Identification and Structure of the Nerve Growth Factor Binding Site on TrkA. Biochemical and Biophysical Research Communications. 282(1). 131–141. 32 indexed citations

17.

Bennett, Gavin, et al.. (1998). Neurogenic oedema and vasodilatation. Neuroreport. 9(7). 1513–1518. 17 indexed citations

18.

Bennett, Gavin, et al.. (1998). Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain. 77(3). 315–322. 98 indexed citations

19.

Bennett, Gavin, Neil Garrett, Lara T. Diemel, Susan D. Brain, & David R. Tomlinson. (1998). Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor. British Journal of Pharmacology. 124(7). 1573–1579. 29 indexed citations

20.

Asopa, Vipin, Alan Robertson, Anthony R. Clarke, et al.. (1997). Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor. Nature Biotechnology. 15(7). 668–672. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact